We are live on ! Find out more
PVI

Pura Vida Investments Portfolio holdings

AUM $14.9M
1-Year Est. Return 38.76%
This Fund
S&P 500
This Quarter Est. Return
+10.46%
1 Year Est. Return
+38.76%
3 Year Est. Return
+26.8%
5 Year Est. Return
+25.03%
10 Year Est. Return
+1,723.84%
AUM
$235M
AUM Growth
+$15.3M
Cap. Flow
+$7.44M
Cap. Flow %
3.16%
Top 10 Hldgs %
31.26%
Holding
99
New
22
Increased
25
Reduced
15
Closed
25

Top Buys

Rank Stock Value
1
MDT icon
Medtronic
MDT
+$6.47M
2
CNC icon
Centene
CNC
+$4.68M
3
SYK icon
Stryker
SYK
+$4.47M
4
AET
Aetna Inc
AET
+$4.31M
5
GSK icon
GSK
GSK
+$4.18M

Top Sells

Rank Stock Value
1
AGN
Allergan plc
AGN
+$7.97M
2
ABBV icon
AbbVie
ABBV
+$5.99M
3
A icon
Agilent Technologies
A
+$3.59M
4
PFE icon
Pfizer
PFE
+$2.77M
5
ELGX
Endologix Inc
ELGX
+$2.66M

Sector Composition

Rank Sector Weight
1 Healthcare 62.78%
2 Financials 4.02%
3 Industrials 1.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ATHN
26
DELISTED
Athenahealth, Inc.
ATHN
$4.14M 1.76%
30,000
– –
CELG
27
DELISTED
Celgene Corp
CELG
$4.13M 1.76%
41,875
+22,750
+119% +$2.35M
ABT icon
28
Abbott
ABT
$188B
$3.93M 1.67%
100,000
-25,000
-20% -$995K
WMGI
29
DELISTED
Wright Medical Group Inc
WMGI
$3.91M 1.66%
225,000
+13,078
+6% +$240K
CVS icon
30
CVS Health
CVS
$122B
$3.83M 1.63%
+40,000
New +$3.99M
TMO icon
31
PUT
Thermo Fisher Scientific
TMO
$222B
$3.69M 1.57%
25,000
-5,000
-17% -$738K
IVC
32
DELISTED
Invacare Corporation
IVC
$3.55M 1.51%
292,500
+67,500
+30% +$796K
CYNA
33
DELISTED
CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA)
CYNA
$3.36M 1.43%
200,845
+6,384
+3% +$85.9K
SPNC
34
DELISTED
Spectranetics Corp
SPNC
$3.27M 1.39%
175,000
-95,989
-35% -$1.69M
JAZZ icon
35
Jazz Pharmaceuticals
JAZZ
$16.6B
$3.11M 1.32%
22,000
+14,500
+193% +$2.14M
CPHD
36
DELISTED
Cepheid Inc
CPHD
$2.92M 1.24%
+95,000
New +$2.87M
CYNO
37
DELISTED
Cynosure, Inc. Class A
CYNO
$2.92M 1.24%
+60,000
New +$2.85M
XENT
38
DELISTED
Intersect ENT, Inc
XENT
$2.78M 1.18%
+215,000
New +$3.37M
ISEE
39
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$2.68M 1.14%
52,500
+20,000
+62% +$994K
CSII
40
DELISTED
Cardiovascular Systems, Inc.
CSII
$2.67M 1.14%
+145,289
New +$2.27M
ELGX
41
DELISTED
Endologix Inc
ELGX
$2.55M 1.09%
20,500
-23,110
-53% -$2.66M
AMRN
42
Amarin Corp
AMRN
$299M
$2.35M 1%
54,375
– –
SIEN
43
DELISTED
Sientra, Inc.
SIEN
$2.3M 0.98%
35,000
+6,052
+21% +$417K
HRC
44
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
$2.27M 0.96%
+45,000
New +$2.27M
MDVN
45
DELISTED
MEDIVATION, INC.
MDVN
$2.19M 0.93%
36,250
-1,000
-3% -$56.7K
VAR
46
PUT
DELISTED
Varian Medical Systems, Inc.
VAR
$2.06M 0.87%
+28,510
New +$2.07M
AKRX
47
DELISTED
Akorn Inc
AKRX
$2.02M 0.86%
71,000
+42,500
+149% +$1.18M
AVXS
48
DELISTED
AveXis, Inc. Common Stock
AVXS
$1.93M 0.82%
+50,800
New +$1.72M
KITE
49
DELISTED
Kite Pharma, Inc.
KITE
$1.86M 0.79%
37,250
– –
AGN
50
DELISTED
Allergan plc
AGN
$1.83M 0.78%
7,920
-34,580
-81% -$7.97M
1
2
3 4

Similar funds

BCA
Boundary Creek Advisors New York $15.3M AUM 0.41% 1-Year Est. Return
RC
Raine Capital New York $14.1M AUM 33.16% 1-Year Est. Return
DOFI
DCVC Opportunity Fund II Palo Alto, California $13.9M AUM 8.04% 1-Year Est. Return
SR
Swiss Re Zurich, Switzerland $16.4M AUM
SCI
SkyBridge Capital II New York $13.1M AUM 3.36% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
GBCP
Glade Brook Capital Partners Greenwich, Connecticut $12.8M AUM
SCTC
Samsung C&T Corporation Seoul, South Korea $17.2M AUM 23.45% 1-Year Est. Return

Pura Vida Investments's Q2 2016 Portfolio in Review

As of Q2 2016, Pura Vida Investments held 99 positions worth $235M, up 7% from $220M the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Pura Vida Investments deployed $7.44M of net new capital in Q2 2016, opening 22 new positions and adding to 25 existing holdings. Its largest new stake was Medtronic: 80,000 shares worth $6.94M.

By sector, the portfolio is most concentrated in Healthcare at 63% of assets, up from 60% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Allergan plc, an estimated $7.97M trimmed.

  • Pura Vida Investments's largest Q2 2016 buy was Medtronic: 80,000 shares worth $6.94M.
  • Pura Vida Investments added most to Centene in Q2 2016, an estimated $4.68M increase.
  • Pura Vida Investments's biggest Q2 2016 reduction was Allergan plc, cutting an estimated $7.97M.
  • Pura Vida Investments fully exited AbbVie in Q2 2016, selling an estimated $5.99M.
  • Pura Vida Investments's ten largest holdings make up 31% of its $235M portfolio in Q2 2016.
  • Pura Vida Investments opened 22 new positions and closed 25 in Q2 2016.
  • Pura Vida Investments's portfolio value rose 7% quarter-over-quarter to $235M.

Based on Pura Vida Investments's 13F filing for Q2 2016, filed 15 Aug 2016.